The award-winning French novelist tells Al Majalla about the inspiration behind his book, 'At Night All Blood Is Black,' and the challenges of merging fact with fiction
Women and girls caught in a wave of appalling sexual violence in the country's civil war tell their stories as international human rights groups and on-the-ground organisations warn of the danger
The award-winning author, documentary-maker, and former presidential candidate talks to Al Majalla about Elon Musk being a 'tragic god' and how our environmental paradigm shift is changing things
US academic Jonathan Gribetz asks why Palestinian nationalists in Lebanon set up a research centre on Zionism, why it was important, what fate had in store for it, and what lessons can be drawn
Showcasing the traditions of different Saudi provinces and performing British classics with the Royal Philharmonic (and even an Adele song), these Saudi artists left their mark on the British capital
Our bi-monthly look at the Arab world's publishing scene includes the reckless death of a literary great, a sharp analysis of populism, and pre-Platonic thought
What entered school curriculum in the late 50s under the influence of Crown Prince Faisal experienced a renaissance with the advent of the internet, which continues to this day
The Kingdom's latest addition to the world's premier heritage sits on an ancient trade route and brought together various faiths, creating a historic treasure trove that has been recognised by UNESCO
The US election coincides with an escalating confrontation between Israel and Iran. Both come with global implications, so we combined the two issues for our November Cover Story.
An austere ex-chemist teacher who has problems inspiring or engaging audiences was the last viable leadership option once Israel killed Hassan Nasrallah and Hashem Saffiedine. Who is he?
The award-winning French novelist tells Al Majalla about the inspiration behind his book, 'At Night All Blood Is Black,' and the challenges of merging fact with fiction
The Kingdom is working with European partners in its war on drugs. But with such stellar profits to be made and such keen demand, it has been an uphill battle.